In accordance with the Food and Drug Safety Administration's change order for pharmaceutical manufacturing (import) items (Drug Safety Policy Division-No. 6100, effective date 2011.10.28), the precautions for use of Gabapen Capsule, Limerin Capsule, Melix Capsule, Celtic Soft Capsule, Alprin Tablet, Acer Capsule, Inhipla Tablet, Inhiplat Tablet, and Janitine Capsule have been changed.
For further details, please refer to the ‘Product Introduction’ section and attached documents.